ESG Report

Overview

The report presents BAP Pharma's 2023 baseline carbon footprint of 135,663.7 tCO2e across Scopes 1, 2 and 3. It highlights the elimination of 90% of single-use plastics in office space, 100% renewable energy use at the UK office, and community programmes covering health, education, environment and charities. The company also reports completing CDP's full corporate disclosure, receiving an EcoVadis score of 69/100, and pursuing near-term targets and net-zero by 2050.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services